Confinement and Spondyloarthritis Treatment

Impact of Confinement on the Treatment of Spondyloarthritis.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04355923

Enrollment

1000

Registered

2020-04-21

Start date

2020-04-20

Completion date

2020-09-01

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spondyloarthritis

Brief summary

Evaluate the impact of confinement on treatment use in spondyloarthritis. Study hypothesis that with the confinement, subjects will stop their treatment. The main objective is to study the impact of confinement on treatment. And secondly to look for for specific psychological profile linked to the interruption of the treatment. the study population consists of patients with spondyloarthritis and belonging to a patient association (ACS). All patients over 18 are included. A mailing questionnaire will be send to all patients. data on diseases activity and treatment will be collected

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Inclusion criteria

* spondyloarthritis, * age over 18 ans * treatment by NSAID or biological treatment to be part of the patient association "ACS" (action contre les spondylarthropathies).

Design outcomes

Primary

Measure	Time frame	Description
treatment use	1 month	treatment continuation

Secondary

Measure	Time frame	Description
activity of disease	1 week	number of crisis
psychological aspects	1 month	Ten Item Personality Inventory rated on a scale from 1, disagree strongly, to 7, agree strongly)

Countries

France

Outcome results